Literature DB >> 387504

Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.

G Sachse, B Willms.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387504     DOI: 10.1007/bf01235884

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia.

Authors:  W Puls; U Keup; H P Krause; G Thomas; F Hoffmeister
Journal:  Naturwissenschaften       Date:  1977-10

2.  alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial origin.

Authors:  D D Schmidt; W Frommer; B Junge; L Müller; W Wingender; E Truscheit; D Schäfer
Journal:  Naturwissenschaften       Date:  1977-10

3.  Influence of an -amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man.

Authors:  W Puls; U Keup
Journal:  Diabetologia       Date:  1973-04       Impact factor: 10.122

4.  Inhibition of sucrase by tris in rat and man, demonstrated by oral loading tests with sucrose.

Authors:  W Puls; U Keup
Journal:  Metabolism       Date:  1975-01       Impact factor: 8.694

5.  Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.

Authors:  R J Walton; I T Sherif; G A Noy; K G Alberti
Journal:  Br Med J       Date:  1979-01-27

6.  Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor.

Authors:  W F Caspary
Journal:  Lancet       Date:  1978-06-10       Impact factor: 79.321

  6 in total
  17 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of Acarbose.

Authors:  T Salvatore; D Giugliano
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Effect of acarbose on carbohydrate tolerance during administration of a fibre-free formula diet on healthy subjects.

Authors:  I E Walter-Sack; A Ittner-Holland; G Wolfram; N Zoellner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.

Authors:  L O Uttenthal; O O Ukponmwan; M Ghiglione; S R Bloom
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

4.  Effect of a long-term acarbose therapy on the metabolic control of sulphonylurea-treated diabetic patients.

Authors:  G Sachse; H Laube; E Mäser; K Federlin
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

5.  Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.

Authors:  J Gerard; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus.

Authors:  G Dimitriadis; S Raptis; A Raptis; E Hatziagelaki; A Mitrakou; P Halvatsiotis; S Ladas; I Hillebrand
Journal:  Klin Wochenschr       Date:  1986-05-02

7.  [Continuous blood glucose monitoring: the acute effect of acarbose on blood glucose variations].

Authors:  B L Herrmann; H Schatz; A Pfeiffer
Journal:  Med Klin (Munich)       Date:  1998-11-15

8.  Delaying carbohydrate absorption in noninsulin-dependent diabetes mellitus: useful therapy?

Authors:  H S Füessl
Journal:  Klin Wochenschr       Date:  1987-05-04

Review 9.  Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  S P Clissold; C Edwards
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes.

Authors:  D R Buchanan; A Collier; E Rodrigues; A M Millar; R S Gray; B F Clarke
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.